These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25498752)

  • 1. ADAMTS13 content and VWF multimer and triplet structure in commercially available VWF/FVIII concentrates.
    Kannicht C; Fisseau C; Hofmann W; Kröning M; Fuchs B
    Biologicals; 2015 Mar; 43(2):117-22. PubMed ID: 25498752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S; Carlson M; Hillarp A
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.
    Gritsch H; Schrenk G; Weinhappl N; Mellgård B; Ewenstein B; Turecek PL
    J Blood Med; 2022; 13():649-662. PubMed ID: 36405429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.
    Cao W; Krishnaswamy S; Camire RM; Lenting PJ; Zheng XL
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7416-21. PubMed ID: 18492805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.
    Peyvandi F; Mannucci PM; Valsecchi C; Pontiggia S; Farina C; Retzios AD
    Am J Hematol; 2013 Oct; 88(10):895-8. PubMed ID: 23813910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.
    Metzner HJ; Hermentin P; Cuesta-Linker T; Langner S; Müller HG; Friedebold J
    Haemophilia; 1998; 4 Suppl 3():25-32. PubMed ID: 10028315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
    Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
    Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
    Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
    J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
    Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
    Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model.
    Raquet E; Stockschläder M; Dickneite G
    Haemophilia; 2011 Sep; 17(5):808-14. PubMed ID: 21726357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor containing factor VIII concentrates.
    Berntorp E
    Haemophilia; 1999 May; 5 Suppl 2():60-3. PubMed ID: 23401902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay.
    Riddell A; Vinayagam S; Gomez K; Laffan M; McKinnon T
    Res Pract Thromb Haemost; 2019 Jan; 3(1):126-135. PubMed ID: 30656286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.
    Raquet E; Stockschlaeder M; Mueller-Cohrs J; Zollner S; Pragst I; Dickneite G
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):515-21. PubMed ID: 25767894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience.
    Auerswald G; Kreuz W
    Haemophilia; 2008 Nov; 14 Suppl 5():39-46. PubMed ID: 18786009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy.
    Drury-Stewart DN; Lannert KW; Chung DW; Teramura GT; Zimring JC; Konkle BA; Gammill HS; Johnsen JM
    PLoS One; 2014; 9(11):e112935. PubMed ID: 25409031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate).
    Stadler M; Gruber G; Kannicht C; Biesert L; Radomski KU; Suhartono H; Pock K; Neisser-Svae A; Weinberger J; Römisch J; Svae TE
    Biologicals; 2006 Dec; 34(4):281-8. PubMed ID: 16500114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative and quantitative analysis of von Willebrand factor contained in a very high-purity plasma-derived FVIII concentrate.
    Samor B; Michalski C; Brandin MP; Andre MH; Chtourou S; Tellier Z
    Vox Sang; 2012 Jul; 103(1):35-41. PubMed ID: 22239246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.